- Conditions
- Premature Ovarian Failure
- Interventions
- Dehydroepiandrosterone, Placebo
- Dietary Supplement
- Lead sponsor
- David H. Barad
- Other
- Eligibility
- 21 Years to 39 Years · Female only
- Enrollment
- 5 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2011
- U.S. locations
- 1
- States / cities
- New York, New York
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Showing 697–720
of 855
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Alcoholism
- Interventions
- Baclofen, Cyproheptadine
- Drug
- Lead sponsor
- Brown University
- Other
- Eligibility
- 21 Years to 65 Years
- Enrollment
- 14 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 1
- States / cities
- Providence, Rhode Island
- Conditions
- Urinary Tract Infections
- Interventions
- Cranberry juice, Placebo cranberry juice
- Drug · Dietary Supplement
- Lead sponsor
- National Center for Complementary and Integrative Health (NCCIH)
- NIH
- Eligibility
- 18 Years to 40 Years · Female only
- Enrollment
- 319 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2009
- U.S. locations
- 1
- States / cities
- Ann Arbor, Michigan
- Conditions
- Uveitis Related Cystoid Macular Edema, Cystoid Macular Edema, Postoperative
- Interventions
- OCS-01
- Drug
- Lead sponsor
- Quan Dong Nguyen
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 28 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 8
- States / cities
- Beverly Hills, California • Huntington Beach, California • Los Angeles, California + 5 more
- Conditions
- Progressive Multiple Sclerosis, Fatigue
- Interventions
- N-acetyl cysteine, Placebo
- Drug
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Polycystic Ovary Syndrome
- Interventions
- LIK066, Placebo
- Drug
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Eligibility
- 18 Years to 40 Years · Female only
- Enrollment
- 29 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 2
- States / cities
- Springfield, Missouri • Philadelphia, Pennsylvania
- Conditions
- Alzheimer's Disease
- Interventions
- Dimebon, Placebo
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 742 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 93
- States / cities
- Mobile, Alabama • Northport, Alabama • Little Rock, Arkansas + 82 more
- Conditions
- Alcohol Abuse
- Interventions
- Puerarin, Placebo
- Drug
- Lead sponsor
- Mclean Hospital
- Other
- Eligibility
- 21 Years to 45 Years
- Enrollment
- 16 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2011
- U.S. locations
- 1
- States / cities
- Belmont, Massachusetts
- Conditions
- Frontotemporal Lobar Degeneration
- Interventions
- Tolcapone, Placebo
- Drug
- Lead sponsor
- Columbia University
- Other
- Eligibility
- 40 Years to 85 Years
- Enrollment
- 28 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2016
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Pharmacokinetics
- Interventions
- Nafamostat Mesilate, Placebo
- Drug
- Lead sponsor
- Ensysce Biosciences
- Industry
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 17 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2021
- U.S. locations
- 1
- States / cities
- Phoenix, Arizona
- Conditions
- Breast Cancer, Chronic Pain Due to Malignancy (Finding)
- Interventions
- Sulfasalazine, Placebos
- Drug
- Lead sponsor
- University of Arizona
- Other
- Eligibility
- 18 Years to 94 Years · Female only
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 2
- States / cities
- Tucson, Arizona
- Conditions
- Parkinson's Disease
- Interventions
- Reduced Glutathione 100mg, Reduced Glutathione 200mg, Placebo
- Drug
- Lead sponsor
- Bastyr University
- Other
- Eligibility
- 21 Years and older
- Enrollment
- 45 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 2
- States / cities
- Kenmore, Washington • Seattle, Washington
- Conditions
- Diabetic Neuropathy
- Interventions
- QR-333
- Drug
- Lead sponsor
- Quigley Pharma, Inc.
- Industry
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 140 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 19
- States / cities
- Birmingham, Alabama • Fountain Valley, California • Lakewood, California + 14 more
- Conditions
- COVID-19, Acute Respiratory Distress Syndrome (ARDS)
- Interventions
- Razuprotafib Subcutaneous Solution, Placebo Subcutaneous Solution
- Drug
- Lead sponsor
- EyePoint Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 31 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2021
- U.S. locations
- 7
- States / cities
- Los Angeles, California • Orange, California • Washington D.C., District of Columbia + 4 more
- Conditions
- Food Allergy
- Interventions
- FAHF-2 (TM)
- Drug
- Lead sponsor
- Li, Xiu-Min, M.D.
- Individual
- Eligibility
- 12 Years to 45 Years
- Enrollment
- 68 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007 – 2012
- U.S. locations
- 2
- States / cities
- Little Rock, Arkansas • New York, New York
- Conditions
- Opioid Use Disorder, Cannabis Use
- Interventions
- Cannabis, Placebo Cannabis, Intranasal Opioid Agonist, Oral Opioid Agonist
- Drug
- Lead sponsor
- Shanna Babalonis, PhD
- Other
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2031
- U.S. locations
- 1
- States / cities
- Lexington, Kentucky
- Conditions
- Depressive Disorder
- Interventions
- Carbidopa/levodopa, Placebo, Exercise training, Control
- Drug · Behavioral
- Lead sponsor
- New York State Psychiatric Institute
- Other
- Eligibility
- 60 Years to 100 Years
- Enrollment
- 1 participant
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Weight Loss, Obesity, Childhood, Obesity
- Interventions
- Lomaira 8Mg Tablet
- Drug
- Lead sponsor
- Loma Linda University
- Other
- Eligibility
- 12 Months to 75 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 2
- States / cities
- Loma Linda, California
- Conditions
- Nicotine Dependence
- Interventions
- Tolcapone, Sugar Pill
- Drug
- Lead sponsor
- Yale University
- Other
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 36 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2019
- U.S. locations
- 1
- States / cities
- West Haven, Connecticut
- Conditions
- Alcoholism
- Interventions
- Acamprosate, Yohimbine, mCPP, Saline
- Drug
- Lead sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- NIH
- Eligibility
- 21 Years to 65 Years
- Enrollment
- 37 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2011
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Portal Hypertension
- Interventions
- Placebo, Cobiprostone
- Drug
- Lead sponsor
- Sucampo Pharma Americas, LLC
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 9 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 1
- States / cities
- Dallas, Texas
- Conditions
- Celiac Disease
- Interventions
- larazotide acetate, Placebo
- Drug
- Lead sponsor
- 9 Meters Biopharma, Inc.
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2007
- U.S. locations
- 9
- States / cities
- Scottsdale, Arizona • San Diego, California • Boston, Massachusetts + 6 more
- Conditions
- Muscle Damage, Muscle Soreness
- Interventions
- Pasture-raised whey protein, Conventional whey protein, Placebo
- Dietary Supplement
- Lead sponsor
- Indiana University
- Other
- Eligibility
- 18 Years to 40 Years
- Enrollment
- 39 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- Bloomington, Indiana
- Conditions
- Wound Heal
- Interventions
- Donepezil, Placebo oral tablet, Topical Zinc Oxide
- Drug
- Lead sponsor
- University of Maryland, Baltimore
- Other
- Eligibility
- 20 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2023
- U.S. locations
- 1
- States / cities
- Easton, Maryland